Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.62 |
| ▸ | NPC1 | O15118 | 7/20 | 0.62 |
| ▸ | HPGD | P15428 | 6/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.62 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.62 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.62 |
| ▸ | RELA | Q04206 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | CASP1 | P29466 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL6835154 | 0.98 | RAB9A (0.60) | RAB9ANPC1HPGDSMN1; SMN2TP53 | |
| SCHEMBL27945491 | 0.95 | RAB9A (0.57) | RAB9ANPC1HPGDSMN1; SMN2TP53 | |
| Trifluoroacetic Acid SCHEMBL28285603 | 0.89 | HDAC3 (0.54) | RAB9ANPC1HPGDSMN1; SMN2TP53 | |
| SCHEMBL9495199 | 0.85 | ALDH1A1 (0.61) | RAB9ANPC1HPGDSMN1; SMN2TP53 | |
| SCHEMBL28472449 | 0.85 | RAB9A (0.49) | RAB9ANPC1HPGDSMN1; SMN2TP53 | |
| Hydrochloric Acid SCHEMBL27412610 | 0.84 | RAB9A (0.51) | RAB9ANPC1HPGDSMN1; SMN2TP53 | |
| SCHEMBL9147021 | 0.84 | RAB9A (0.48) | RAB9ANPC1HPGDSMN1; SMN2TP53 | |
| Hydrochloric Acid SCHEMBL27388065 | 0.84 | ALDH1A1 (0.60) | RAB9ANPC1HPGDSMN1; SMN2TP53 | |
| SCHEMBL11097691 | 0.83 | KMT2A (0.55) | RAB9ANPC1HPGDSMN1; SMN2TP53 | |
| SCHEMBL1433300 | 0.82 | NPC1 (0.60) | RAB9ANPC1HPGDSMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 690 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4129065-B1 | MAMMAL REPELLENT | SCENT SCIENCE INT INC (JP) | 2025-06-11 | — | — | EP | claimed |
| CN-115557928-B | Synthesis method of 2-chlorothiophene-5-formic acid | 浙江燎原药业有限公司 | 2024-03-19 | — | — | CN | claimed |
| US-20230363389-A1 | MAMMAL REPELLENT | SCENT SCIENCE INTERNATIONAL INC. (JP) | 2023-11-16 | — | — | US | claimed |
| EP-4129065-A1 | MAMMAL REPELLENT | Scent Science International Inc. (JP) | 2023-02-08 | — | — | EP | claimed |
| CN-115557928-A | Synthetic method of 2-chlorothiophene-5-formic acid | 浙江燎原药业股份有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-113135933-B | Aggregation-induced luminescent material based on thieno [3,4-b ] thiophene, and preparation method and application thereof | 山西大学 | 2022-03-18 | — | — | CN | claimed |
| CN-105198793-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2019-08-13 | — | — | CN | claimed |
| CN-109574986-A | 6- amino benzo [b] thiophene-2-carboxylic acid derivative and its application in terms of anti-epileptic | 聊城大学 | 2019-04-05 | — | — | CN | claimed |
| CN-107141279-B | A kind of preparation method of 3- (thiophene -2- base) hexamethylene -2- ketenes derivative | 山西大学 | 2019-04-05 | — | — | CN | claimed |
| CN-105810818-B | A kind of anode buffer layer material and its preparation method and application based on copper chloride-graphene oxide compound | 苏州大学 | 2018-08-24 | — | — | CN | claimed |
| CN-101282957-A | New pharmaceutical compounds | ORION CORP (FI) | 2008-10-08 | — | — | CN | claimed |
| CN-1901902-A | Thiophene and benzothiophene hydroxamic acid derivatives | ATON PHARMA INC (US) | 2007-01-24 | — | — | CN | claimed |
| CN-1882563-A | Antidiabetic compounds comprising benzofuran and benzothiophene derivatives | MERCK PATENT GMBH (DE) | 2006-12-20 | — | — | CN | claimed |
| CN-1791412-A | Novel compounds and their use in therapy | SOLVAY PHARM GMBH (NL) | 2006-06-21 | — | — | CN | claimed |
| EP-1635839-A2 | BENZO[4,5]THIENO[2,3-D]PYRIMIDIN-4-ONES AND THEIR USE IN THERAPY | Solvay Pharmaceuticals B.V. (NL) | 2006-03-22 | — | — | EP | claimed |
| US-20050176742-A1 | Novel compounds and their use in therapy | SOLVAY PHARMACEUTICALS B.V. (NL) | 2005-08-11 | — | — | US | claimed |
| WO-2005032527-A2 | BENZO (4, 5) THIENO (2, 3-D) PYRIMIDIN-4-ONES AND THEIR USE IN THERAPY | SOLVAY PHARMACEUTICALS B.V. (NL) | 2005-04-14 | — | — | WO | claimed |
| US-20050038053-A1 | Novel compounds and their use in therapy | SOLVAY PHARMACEUTICALS B.V. (NL) | 2005-02-17 | — | — | US | claimed |
| US-4634687-A | COCATALYST FOR COORDINATION CATALYST | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1987-01-06 | — | — | US | claimed |
| US-4526941-A | Contacting alpha olefin with catalyst comprising organomagnesium compound, titanium compound, nitrogen or sulfur heterocyclic compound, slurry component and organometallic component | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1985-07-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176742-A1 | Novel compounds and their use in therapy | HSD17B11, HSD17B2, HSD17B1 | RAB9A 3568/4885NPC1 618/4885HPGD 96/4885 |
| US-20050038053-A1 | Novel compounds and their use in therapy | HSD17B11, HSD17B2, HSD17B1 | RAB9A 3568/4885NPC1 618/4885HPGD 96/4885 |
| US-20230363389-A1 | MAMMAL REPELLENT | TMT1A, L3MBTL1, NAAA | RAB9A 2220/4885NPC1 1805/4885HPGD 4393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.